The Florey Institute of Neuroscience and Mental Health
13
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
87.5%
+1.0% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke
Role: lead
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Role: lead
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Role: collaborator
Deferiprone to Delay Dementia (The 3D Study)
Role: collaborator
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
Role: collaborator
A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS
Role: lead
Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence
Role: lead
High-dose Intravenous Vitamin C in Patients With Septic Shock
Role: collaborator
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
Role: collaborator
Cognition And Neocortical Volume After Stroke
Role: lead
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
Role: collaborator
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Role: collaborator
Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
Role: collaborator
All 13 trials loaded